vs

Side-by-side financial comparison of Clean Energy Fuels Corp. (CLNE) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

Clean Energy Fuels Corp. is the larger business by last-quarter revenue ($2.0B vs $186.7M, roughly 10.8× NEOGENOMICS INC). Clean Energy Fuels Corp. runs the higher net margin — -6.7% vs -57.9%, a 51.2% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -0.0%). Over the past eight quarters, Clean Energy Fuels Corp.'s revenue compounded faster (354.7% CAGR vs 6.5%).

Bloom Energy is an American public company that designs and manufactures solid oxide fuel cells (SOFCs) which independently produce electricity onsite for power generation in data centers, manufacturing, and other commercial sectors. Founded in 2001 and headquartered in San Jose, California; its fuel cell technology generates electricity through a chemical conversion process, which differs from most other power sources reliant on combustion, and can use natural gas, biogas or hydrogen as fuel...

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

CLNE vs NEO — Head-to-Head

Bigger by revenue
CLNE
CLNE
10.8× larger
CLNE
$2.0B
$186.7M
NEO
Growing faster (revenue YoY)
NEO
NEO
+11.1% gap
NEO
11.1%
-0.0%
CLNE
Higher net margin
CLNE
CLNE
51.2% more per $
CLNE
-6.7%
-57.9%
NEO
Faster 2-yr revenue CAGR
CLNE
CLNE
Annualised
CLNE
354.7%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLNE
CLNE
NEO
NEO
Revenue
$2.0B
$186.7M
Net Profit
$-135.0M
$-108.0M
Gross Margin
43.3%
Operating Margin
88.6%
46.9%
Net Margin
-6.7%
-57.9%
Revenue YoY
-0.0%
11.1%
Net Profit YoY
42.0%
EPS (diluted)
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLNE
CLNE
NEO
NEO
Q1 26
$2.0B
$186.7M
Q4 25
$112.3M
$190.2M
Q3 25
$106.1M
$187.8M
Q2 25
$102.6M
$181.3M
Q1 25
$103.8M
$168.0M
Q4 24
$109.3M
$172.0M
Q3 24
$104.9M
$167.8M
Q2 24
$98.0M
$164.5M
Net Profit
CLNE
CLNE
NEO
NEO
Q1 26
$-135.0M
$-108.0M
Q4 25
$-43.0M
Q3 25
$-23.8M
$-27.1M
Q2 25
$-20.2M
$-45.1M
Q1 25
$-135.0M
$-25.9M
Q4 24
$-30.2M
Q3 24
$-18.2M
$-17.7M
Q2 24
$-16.3M
$-18.6M
Gross Margin
CLNE
CLNE
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
CLNE
CLNE
NEO
NEO
Q1 26
88.6%
46.9%
Q4 25
-9.5%
-7.1%
Q3 25
-12.8%
-14.4%
Q2 25
-9.0%
-26.3%
Q1 25
-121.7%
-16.6%
Q4 24
-11.8%
-10.7%
Q3 24
-8.1%
-12.6%
Q2 24
-5.7%
-13.3%
Net Margin
CLNE
CLNE
NEO
NEO
Q1 26
-6.7%
-57.9%
Q4 25
-38.3%
Q3 25
-22.4%
-14.4%
Q2 25
-19.7%
-24.9%
Q1 25
-130.1%
-15.4%
Q4 24
-27.6%
Q3 24
-17.3%
-10.5%
Q2 24
-16.6%
-11.3%
EPS (diluted)
CLNE
CLNE
NEO
NEO
Q1 26
$-0.13
Q4 25
$-0.21
Q3 25
$-0.11
Q2 25
$-0.09
Q1 25
$-0.60
Q4 24
$-0.14
Q3 24
$-0.08
Q2 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLNE
CLNE
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$552.0K
$146.1M
Total DebtLower is stronger
$52.0K
Stockholders' EquityBook value
$565.1M
$828.8M
Total Assets
$1.1B
$1.3B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLNE
CLNE
NEO
NEO
Q1 26
$552.0K
$146.1M
Q4 25
$156.1M
$159.6M
Q3 25
$232.2M
$164.1M
Q2 25
$240.8M
$154.7M
Q1 25
$226.6M
$346.2M
Q4 24
$217.5M
$367.0M
Q3 24
$243.5M
$362.0M
Q2 24
$249.3M
$355.1M
Total Debt
CLNE
CLNE
NEO
NEO
Q1 26
$52.0K
Q4 25
$226.8M
$341.9M
Q3 25
$284.3M
Q2 25
$277.9M
Q1 25
$271.6M
Q4 24
$265.4M
$541.1M
Q3 24
$264.1M
Q2 24
$263.0M
Stockholders' Equity
CLNE
CLNE
NEO
NEO
Q1 26
$565.1M
$828.8M
Q4 25
$559.4M
$836.6M
Q3 25
$585.2M
$838.3M
Q2 25
$590.8M
$854.0M
Q1 25
$596.7M
$888.3M
Q4 24
$713.3M
$902.3M
Q3 24
$724.8M
$908.2M
Q2 24
$723.0M
$915.9M
Total Assets
CLNE
CLNE
NEO
NEO
Q1 26
$1.1B
$1.3B
Q4 25
$1.1B
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$1.1B
$1.4B
Q1 25
$1.1B
$1.6B
Q4 24
$1.2B
$1.6B
Q3 24
$1.2B
$1.6B
Q2 24
$1.2B
$1.6B
Debt / Equity
CLNE
CLNE
NEO
NEO
Q1 26
0.00×
Q4 25
0.41×
0.41×
Q3 25
0.49×
Q2 25
0.47×
Q1 25
0.46×
Q4 24
0.37×
0.60×
Q3 24
0.36×
Q2 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLNE
CLNE
NEO
NEO
Operating Cash FlowLast quarter
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLNE
CLNE
NEO
NEO
Q1 26
$-8.1M
Q4 25
$13.1M
$1.3M
Q3 25
$13.1M
$8.9M
Q2 25
$35.9M
$20.3M
Q1 25
$23.4M
$-25.3M
Q4 24
$21.9M
$9.8M
Q3 24
$21.4M
$9.2M
Q2 24
$18.8M
$13.9M
Free Cash Flow
CLNE
CLNE
NEO
NEO
Q1 26
Q4 25
$6.5M
$-6.5M
Q3 25
$6.5M
$570.0K
Q2 25
$30.9M
$14.0M
Q1 25
$15.9M
$-29.8M
Q4 24
$10.3M
$-1.8M
Q3 24
$42.0K
$-1.6M
Q2 24
$4.8M
$814.0K
FCF Margin
CLNE
CLNE
NEO
NEO
Q1 26
Q4 25
5.8%
-3.4%
Q3 25
6.1%
0.3%
Q2 25
30.2%
7.7%
Q1 25
15.4%
-17.8%
Q4 24
9.5%
-1.0%
Q3 24
0.0%
-0.9%
Q2 24
4.9%
0.5%
Capex Intensity
CLNE
CLNE
NEO
NEO
Q1 26
Q4 25
5.9%
4.1%
Q3 25
6.2%
4.4%
Q2 25
4.8%
3.5%
Q1 25
7.2%
2.7%
Q4 24
10.5%
6.7%
Q3 24
20.3%
6.4%
Q2 24
14.2%
8.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons